A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial

1. Climent, M.A.
2. Font, A.
3. Durán, I.
4. Puente, J.
5. José Méndez-Vidal, M.
6. Sáez, M.I.
7. Santander Lobera, C.
8. Ángel Arranz Arija, J.
9. González-del-Alba, A.
10. Sánchez-Hernandez, A.
11. Juan Fita, M.J.
12. Esteban, E.
13. Alonso-Gordoa, T.
14. Mellado Gonzalez, B.
15. Maroto, P.
16. Lázaro-Quintela, M.
17. Cassinello-Espinosa, J.
18. Pérez-Valderrama, B.
19. Garcias, C.
20. Castellano, D.